monovalent bispecific IgG antibodies through novel electrostatic steering mutations at the CH1-CL interface


Domain Annotation: ECOD Classification ECOD Database Homepage

ChainsFamily NameDomain Identifier ArchitecturePossible HomologyHomologyTopologyFamilyProvenance Source (Version)
D [auth B]Helicase_Ce8tjfB1 A: a/b three-layered sandwichesX: RNase A-likeH: RNase A-likeT: RNase A-likeF: Helicase_CECOD (v294.1)
B [auth H]Helicase_Ce8tjfH1 A: a/b three-layered sandwichesX: RNase A-likeH: RNase A-likeT: RNase A-likeF: Helicase_CECOD (v294.1)
C [auth A]Helicase_Ce8tjfA1 A: a/b three-layered sandwichesX: RNase A-likeH: RNase A-likeT: RNase A-likeF: Helicase_CECOD (v294.1)
A [auth L]Helicase_Ce8tjfL1 A: a/b three-layered sandwichesX: RNase A-likeH: RNase A-likeT: RNase A-likeF: Helicase_CECOD (v294.1)

SAbDab Antibody Annotation SAbDab Database Homepage

ChainChain ClassChain SubclassChain TypeAntigen Name(s) Provenance Source
B [auth H],
D [auth B]
Heavy ChainIGHV3 --SAbDab (2026-04-24)
A [auth L],
C [auth A]
Light ChainIGKV1 Kappa-SAbDab (2026-04-24)

Thera-SAbDab Antibody Annotation Thera-SAbDab Database Homepage

ChainNameTargetProvenance Source
B [auth H],
D [auth B]
Runimotamab ERBB2/CD340/HER2, CD3E, TNFRSF9/CD137/4-1BB, SIRPATherapeutic SAbDab (2026-04-24)
A [auth L],
C [auth A]
Anvatabart ERBB2/CD340/HER2, CD3E, SIRPA, TNFRSF9/CD137/4-1BBTherapeutic SAbDab (2026-04-24)